Browsing Centre for Oral Immunobiology and Regenerative Medicine by Author "Dolcetti, L"
Now showing items 1-2 of 2
-
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
Vicencio, JM; Evans, R; Green, R; An, Z; Deng, J; Treacy, C; Mustapha, R; Monypenny, J; Costoya, C; Lawler, K (2022) -
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development
Barber, PR; Mustapha, R; Flores-Borja, F; Alfano, G; Ng, K; Weitsman, G; Dolcetti, L; Mohamed, AA; Wong, F; Vicencio, JM (2022)